James R. Downing, St. Jude Children's Research Hospital (IMAGE)

St. Jude Children's Research Hospital

James R. Downing, St. Jude Children's Research Hospital

Caption

The St. Jude Children's Research Hospital--Washington University Pediatric Cancer Genome Project reports that a highly aggressive form of leukemia in infants has surprisingly few mutations beyond the chromosomal rearrangement that affects the MLL gene. Senior and co-corresponding author is James R. Downing, M.D., St. Jude Children's Research Hospital president and chief executive officer.

Credit

Peter Barta, St. Jude Children's Research Hospital

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.